Drug Target Review Synthetic Biology ebook 2021

Posted: 22 September 2021 | | No comments yet

In this ebook, discover why CRISPR can aid the development of new drugs via loss-of-function screens and how the field of synthetic biology is likely to evolve within the context of health.

The use of synthetic biology has shown vast promise across early drug discovery and development. 

Focusing on CRISPR, Dr Pushpanathan Muthuirulan explores why this technology holds promise to progress pharmacological research. He explains that CRISPR can be used to develop gene-edited cells for drug discovery processes including high-throughput screens.

Dr Jim Collins additionally reveals how synthetic biology approaches can be utilised throughout the life sciences. He also discusses how this area of research is likely to evolve in the future, with regards to therapeutic development and diagnostics.

Included in this ebook:

  • CRISPR-Cas9-based gene dropout screens: a powerful platform for drug discovery
    Dr Pushpanathan Muthuirulan, Harvard University
  • The diversity of synthetic biology applications
    Dr Jim Collins, MIT and Wyss Institute at Harvard University

    To read this ebook in full, please complete the form below:


    This specialist content is provided to you free-of-charge thanks to the kind support of GenScript and Thermo Fisher Scientific

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.